Pictet Asset Management (Switzerland)’s Medifast MED Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-67,524	Closed	-$7M	–	1991
2023 Q1	$7M	Sell	67,524 -93,506	-58%	-$10.4M	0.01%	705
2022 Q4	$18.6M	Buy	161,030 +15,763	+11%	+$1.84M	0.03%	460
2022 Q3	$15.7M	Sell	145,267 -36,902	-20%	-$5.29M	0.02%	479
2022 Q2	$32.9M	Sell	182,169 -28,350	-13%	-$5.07M	0.05%	359
2022 Q1	$36M	Buy	210,519 +4,834	+2%	+$911K	0.04%	377
2021 Q4	$43.1M	Buy	205,685 +60,665	+42%	+$12.5M	0.04%	367
2021 Q3	$27.9M	Buy	+145,020	New	+$35.7M	0.03%	441

Other funds holding MED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s MED Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) sold out of Medifast (MED) in Q2 2023, closing a stake of 67,524 shares — an estimated $7M sold.

Pictet Asset Management (Switzerland) first reported a position in MED in Q3 2021 and held it in 7 quarters. The position peaked at $43.1M in Q4 2021. 236 funds tracked by Wall St. Rank hold MED as of Q2 2023.

Pictet Asset Management (Switzerland) reported no remaining Medifast position as of Q2 2023 after selling out during the quarter.
Pictet Asset Management (Switzerland) sold 67,524 Medifast shares in Q2 2023, an estimated $7M.
Pictet Asset Management (Switzerland) first reported a position in Medifast in Q3 2021 and held it in 7 quarters.
Pictet Asset Management (Switzerland)'s Medifast position peaked at $43.1M in Q4 2021.
236 funds tracked by Wall St. Rank held Medifast as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.